« Back
Home /
Adebrelimab (Anti-B7-H1 / PD-L1 / CD274)

Adebrelimab (Anti-B7-H1 / PD-L1 / CD274)

Item no.	A2775-1mg
Manufacturer	Selleckchem
CASRN	2247114-85-6
Amount	1 mg
Specific against	other
Available
Information	Adebrelimab (Anti-B7-H1 / PD-L1 / CD274) is a humanized immunoglobulin G4 (IgG4) monoclonal antibody directed against the immunosuppressive ligand programmed cell death-1 ligand 1 (PD-L1, cluster of differentiation 274, CD274) with promising antitumor activity in solid tumors including extensive-stage small-cell lung cancer (SCLC). MW: 145.8 kD.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 1 mg

available

Delivery expected until 9/20/2024

Express Delivery: Save 3 days

Compare

Add to wishlist

Recommend by mail